 |
|
|
|
|
 |
 |
Gastrointestinal Cancer Diagnostics Center of Economic Excellence
Inception: About the CoEE: The Gastrointestinal Cancer Diagnostics CoEE researches state-of-the-art translational medicine for gastrointestinal cancer patients, with hopes of decreasing the overall impact of cancer mortality and morbidity and closing disparity gaps throughout the state. Areas of research include molecular profiling, therapeutic targets, screening technologies, therapy, environmental interactions and population studies, with particular emphasis on esophageal cancer, which is highly prevalent in South Carolina. CoEE faculty were instrumental in the awarding of a 2009 National Cancer Institute Cancer Center designation to the MUSC Hollings Cancer Center Center. In June 2009, MUSC also received a $20 million NIH Clinical and Translational Science Award.
This
CoEE has received $2.8 million in research funding to test novel therapies
through clinical trials. CoEE faculty are conducting clinical trials in
pancreatic, colon, kidney, liver and esophageal cancers. CoEE Chair
Thomas is collaborating on a clinical trial with Cancer Drug Discovery CoEE
Chair Charles Smith to test the success of a new drug for pancreatic cancer
developed in Dr. Smith’s CoEE laboratory. Partners for this CoEE include Roche Carolina and Bank of America. Funding level: CoEE endowed chair:
|
